Breast Cancer Risk Biomarkers in Postmenopausal Women
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Lovaza™
Sponsor: Carol Fabian, MD
Collaborators: GlaxoSmithKline